ARGX.BR Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
argenx SE. Stock Analysis ARGX.BR
United States Health Care Large Cap argenx SE operates as a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland and currently employs 1,148 full-time employees. The company went IPO on 2014-07-10. The company creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
Read More ARGX.BR Chart
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$514.00Volume
48.76KP/E Ratio (TTM)
38.4252 Week Range
Market Cap
42.87BAvg. Volume
84.11KDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 0.87 | 9.62 | 7.41 | 20.72 | - |
EBIT per Share (TTM) | -10.04 | -6.75 | -12.98 | -7.11 | - |
EPS Forward | -13.4 | -7.99 | -13.05 | -5.16 | - |
Annual 
Quarterly
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Net Margin | -14.75 | -0.82 | -1.73 | -0.24 | 0 |
Quick Ratio | 6.1 | 7.88 | 8.17 | 8.7 | 0 |
Current Ratio | 6.26 | 8.44 | 9.18 | 9.75 | 0 |
Price to Earnings (TTM) | 0 | 0 | 0 | 0 | 0 |
price_to_earning | 0 | 0 | 0 | 0 | 0 |
Price to Sales (TTM) | 0 | 0 | 0 | 0 | 0 |
Price to Book | 7.14 | 6.61 | 7.22 | 5.16 | 0 |
Free Cash Flow Margin | 0 | 0 | 0 | 0 | 0 |
Payout Ratio (TTM) | 0 | 0 | 0 | 0 | 0 |
Gross Margin | 0 | 0 | 0.93 | 0.9 | 0 |
Return on Equity (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Assets | -0.27 | -0.14 | -0.23 | -0.07 | 0 |
Return on Assets (TTM) | 0 | 0 | 0 | 0 | 0 |
Return on Invested Capital | -0.36 | -0.16 | -0.25 | -0.07 | 0 |
Inventory Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Receivables Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Asset Turnover (TTM) | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt to Equity | 0 | 0 | 0 | 0 | 0 |
Total Debt to Total Asset | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt to Total Asset | 0 | 0 | 0 | 0 | 0 |
Total Debt to Total Capital | 0.01 | 0 | 0 | 0 | 0 |
Operating Margin | -11.58 | -0.7 | -1.75 | -0.35 | 0 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Jefferies Group
% Portfolio:
1.48 Recent Activity:34.85%
Ron Baron
% Portfolio:
0.39 Recent Activity:-3.25%
George Soros
% Portfolio:
0 Recent Activity:-100.00%
Community-Curated Collections ( With ARGX.BR )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
